@jeanconnorsmd.bsky.social
Intriguing findings from a high-quality prospective study on SVT in #pregnancy and #postpartum. Incident higher, heterogeneous treatment, but low rate of #DVT and #PE. I was surprised and so were the authors. Would love to see the full results. #ISTH2025
MAQI2 data presented at #ISTH2025 shows significant cost reductions for warfarin patients in whom unnecessary aspirin was stopped. This supports the financial benefits of a key #AntithromboticStewardship intervention.
@middeldorps.bsky.social I agree, excellent presentation about Claire and her accomplishments for women’s health
Saskia Middeldorp@middeldorps.bsky.social · last yr.What a fantastic plenary lecture by Prof Jennifer Curnow - in loving and admiring memory of my dear friend Dr Claire McLintock. #ISTH2025
What an inspiring #ISTH2025! It was wonderful to host the global #thrombosis & #hemostasis community in DC. From the latest science & innovations to networking & building new collabs - it had it all! Look out for recordings & other post- @isth.org congress updates. Goodbye & see you @ #ISTH2026!
I have been quiet on the socials for a while, but very excited to be on my way to @isth.org #ISTH2025 ✈️. Let's hope that Bluesky gets to fly too! And I also just realized that it has been 30 years since my first @isth.org meeting in 1995. I haven't missed one single congress. #thrombosis
💡Honoring the impact & memory of the late Claire McLintock, this @ISTH.org grant supports #ISTHEarlyCareer innovative research in women's health issues in #thrombosis & #hemostasis. Learn more ⬇️and apply by ⏳ Sept. 1! t.co/QYL9cUcoav Thank you to all donors who supported this grant! #ISTH2025
Great to be here! #ISTH2025. Looking forward to hearing and supporting all excellent science and scientists from all over the world. #thrombosis
So fun connecting with colleagues in #ASCO25 meeting! Diversity is key. Missing my mentor @jeanconnorsmd.bsky.social !!! trainees from Peru and Mexico interested in Heme!
Pregnancy-Related VTE Risk Perception & Prevention in Risk-Averse Times—Significant Change Required vimeo.com/1072760896 @btsamuelsonmd.bsky.social @marccarriermd.bsky.social @isth.org @worldthrombosisday.bsky.social @thrombosisuk.bsky.social @jeanconnorsmd.bsky.social @bsochaem.bsky.social
Video abstract - VTE prevention strategy - 20250320
Pregnancy-related venous thromboembolism risk perception and prevention in risk-averse times - significant change required; a commentary
vimeo.com
Connected with @pamchmd while at @acc25. Former Boston heme fellow now Chicago attending
The Trump administration pushed out Peter Marks, the nation’s top vaccine regulator and an architect of the U.S. program to rapidly develop coronavirus vaccines.
RFK Jr. forces out Peter Marks, FDA’s top vaccine scientist
In his resignation letter, Marks rebuked Kennedy for seeking “subservient confirmation of his misinformation and lies” about vaccines.
wapo.st
@acc25.bsky.social Isabelle Mahe presents API-CAT Low dose Apixaban noninferior to high dose for recurrent VTE and superior for lower bleeding-another win!
💡 #Semaglutide is the first therapy to ⬇️ #MACE, improve cardiometabolic and kidney outcomes and improves walking capacity, symptoms, and related #QoL in patients with #cvPAD and #T2D #ACC25 #JACCJournals #CardioSky
JACC Journals@jaccjournals.bsky.social · 2y agoDr. Marc Bonaca on the effect of once-weekly subcutaneous #semaglutide on functional capacity in people with #T2D and #cvPAD #ACC25 #JACCJournals
Read Peter Marks' resignation letter from FDA. Shame on #RFKJr, #Trump, #Musk, #Vought and the rest of these monsters driving the American public health and health systems to destruction.
Edward Nirenberg@enirenberg.bsky.social · 2y agoPeter Marks’s resignation letter. Everyone should read this.
ACC25 Mark Bonaca presenting onsemiglutide on pad improvement in the STRIDE trial—clear success
It’s #BloodClotAwarenessMonth. Do your patients know the signs and symptoms of blood clots? Encourage them to learn more about blood clots at www.getouttheclot.com/patient/ #VTEAwareness #WTDay25
Patient - Get Out the Clot
I just took the #GetOutTheClot pledge to improve care for patients with VTE. By uniting with fellow healthcare professionals, we can help patients receive the right treatment at the right time with ac...
getouttheclot.com
This is such an important distinction! It’s also what universities are failing to understand, and it’s not going to save them in the end.
Nicole Bedera@nbedera.bsky.social · 2y agoI’ve seen a lot of assumptions in the media that Trump (and Musk) are targeting institutions with loyalty tests. But that’s not quite right. They’re using dominance tests. And the difference between these two things matter. 🧵
Exciting news! 🎉We’re thrilled to announce the recipients of the 2025 Outstanding Mentor Awards: Denisa Wagner & Robert Medcalf. These awards honor mentors who go above and beyond to inspire, guide & empower early career professionals in thrombosis & hemostasis. Learn more: bit.ly/41FIZQz
Science drives innovation which helps to make a community great. No matter the scale. The academic environment also supports teaching students how to think critically and logically about pressing problems facing humanity.
Stand Up for Science!@standupforscience.net · 2y agoWHY DO YOU STAND UP FOR SCIENCE? ☀️ Tell us how science has impacted your life. We’ll share stories with your representatives, from local reps to Capitol Hill—and on our website, so you can use them to advocate too. ➡ forms.gle/fHekXH8vAmRu...
🚨ATTENTION PUBLIC HEALTH ALLIES!🚨 We have power together. To see our strength and build community, we ask that you wear something 💚green💚 to work on WEDNESDAY to show solidarity and readiness to defend public health. Please spread the word! #courageiscontagious #spreadthecolor
From 2010 to 2016 (latest data I have ), NIH research contributed to EVERY drug approved by the FDA
The ADA was won after a series of battles. This was one of them. 🖤🖤🖤
